Illustration: Vartika Sharma for Bloomberg
Health
Cancer’s Soaring Cost Wrecks Patients’ Finances in a Broken System
The impact on those suffering from cancer is likely to increase if federal health subsidies expire next year.
Jacqueline Trapp was paying down her mortgage and looking forward to early retirement when she got multiple myeloma a decade ago at the age of 50. She’s kept her disease mostly under control since then with a drug that lists for over $800 per pill, taken 21 days a month. It’s her finances that have deteriorated.